<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02862002</url>
  </required_header>
  <id_info>
    <org_study_id>RC12_3975 - 2756</org_study_id>
    <nct_id>NCT02862002</nct_id>
  </id_info>
  <brief_title>Measuring the Effects of Therapeutic Education Program &quot;Caratif&quot; Patient Under Strong Opioids Versus Standard Taking Charge of Patient Pain Receiving Opioid Therapy in Medical Oncology.</brief_title>
  <official_title>Measuring the Effects of Therapeutic Education Program &quot;Caratif&quot; Patient Under Strong Opioids Versus Standard Taking Charge of Patient Pain Receiving Opioid Therapy in Medical Oncology.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique Hopitaux De Marseille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique Hopitaux De Marseille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A first empirical evidence on the difficulties of observance of morphine in cancer patients
      invited a multidisciplinary team to initiate an innovative quality approach. It shows the
      lack of transcript of a comprehensive care causing a problem for monitoring actions
      undertaken for the relief of pain. In addition, two exploratory studies targeting the
      expectations and needs of the Patient Therapeutic Education (E.T.P) receiving strong opioids.

      The E.T.P, public health priority, provides a framework for action and improving care. In
      oncology, the involvement of the patient in pain relief and management of opioids represents
      an axis of intervention more appropriate. Yet, it is not found in literature. In our
      department, we conduct an experimental therapeutic education program type &quot;caratif&quot; and a
      nurse consultation FTE receiving opioids on the model of nursing &quot;care&quot; of J. Watson
      (humanist emphasis promoting interpersonal teaching-learning mobilizing the patient
      experience). The ETP folder and its tools have been continuously validated with patients. The
      heart of the educational process is in the patient's complex path neat oncology and relies on
      interaction and creativity between patient and caregivers.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2013</start_date>
  <completion_date type="Anticipated">March 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain assessment</measure>
    <time_frame>21 days</time_frame>
    <description>Using a digital scale</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Treatment adherence morphine</measure>
    <time_frame>21 days</time_frame>
    <description>Digital Scale / self-administered questionnaire of adherence of Girerd et al [78]</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Strategies Adjustment disease</measure>
    <time_frame>21 days</time_frame>
    <description>Scale MAC (Mental Adjustment to Cancer Scale) French Version: Cayrou et al, 2001 [82]</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety</measure>
    <time_frame>21 days</time_frame>
    <description>Scale HADS (Hospital anxiety and depression seale, French version: Sigmund and Snaith) [83]</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression</measure>
    <time_frame>21 days</time_frame>
    <description>Scale HADS (Hospital anxiety and depression seale, French version: Sigmund and Snaith) [83]</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Pain Management</condition>
  <arm_group>
    <arm_group_label>Therapeutic Patient Education (E.T.P)of type &quot;caratif</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in arm E.T.P benefit of the nursing consultation E.T.P,</description>
  </arm_group>
  <arm_group>
    <arm_group_label>standard care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients receiving standard care of cancer pain.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>therapeutic education of type &quot;caratif</intervention_name>
    <description>study the effects of a therapeutic education program type &quot;caratif&quot;, based on a communication pedagogy, with the patient receiving opioid therapy in medical oncology</description>
    <arm_group_label>Therapeutic Patient Education (E.T.P)of type &quot;caratif</arm_group_label>
    <arm_group_label>standard care</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard care</intervention_name>
    <description>patients receiving standard care of cancer pain.</description>
    <arm_group_label>Therapeutic Patient Education (E.T.P)of type &quot;caratif</arm_group_label>
    <arm_group_label>standard care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult

          -  Cancer patients receiving opioids

          -  Suffering from pain caused by their disease or treatment with chemotherapy and / or
             radiotherapy and / or surgery

          -  Supported within the oncology or palliative care

          -  Receiving at least 3 courses of chemotherapy

          -  Having read, understood and signed the informed consent

          -  Subject beneficiary of a social security scheme or an equivalent -

        Exclusion Criteria:

          -  adults subject to a legal protection measure or unable to consent

          -  Non-beneficiaries of a social security scheme,

          -  persons deprived of liberty by a judicial or administrative decision,

          -  patients with neurological or psychiatric disorders
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Urielle DESALBRES</last_name>
    <role>Study Director</role>
    <affiliation>Assistance Publique Hôpitaux de Marseille</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Florence DUFFAUD</last_name>
    <phone>04.91.38.57.08</phone>
    <email>fduffaud@mail.ap-hm.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jeanne-Francette FUTO</last_name>
    <phone>04 91 38 45 47</phone>
    <email>jeanne.futo@ap-hm.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Assistance Publique Hôpitaux de Marseille Hôpital de la Timone</name>
      <address>
        <city>Marseille</city>
        <zip>13354</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Florence DUFFAUD</last_name>
      <phone>04.91.38.57.08</phone>
      <phone_ext>+33</phone_ext>
      <email>fduffaud@mail.ap-hm.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 5, 2016</study_first_submitted>
  <study_first_submitted_qc>August 9, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 10, 2016</study_first_posted>
  <last_update_submitted>August 9, 2016</last_update_submitted>
  <last_update_submitted_qc>August 9, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 10, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>opioid therapy</keyword>
  <keyword>medical oncology.</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Analgesics, Opioid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

